Concomitant B.I.D. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study11Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) was the promoter of this study.22Presented at the 39th annual ASTRO meeting, Orlando, October 19–23, 1997.

This publication has 64 references indexed in Scilit:

• Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: Results of a double blind randomized trial
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
  Journal of Clinical Oncology, 1995
• Twice‐a‐day radiotherapy for squamous cell carcinoma of the head and neck: The University of Florida experience
  Head & Neck, 1993
• Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
  Radiotherapy and Oncology, 1992
• CORRESPONDENCE: Soft-Laser Therapy for Iatrogenic Mucositis in Cancer Patients Receiving High-Dose Fluorouracil: A Preliminary Report
  JNCI Journal of the National Cancer Institute, 1992
• Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma
  International Journal of Radiation Oncology*Biology*Physics, 1991
• Correlation between free platinum AUC and total platinum measurement 24 h after i.v. bolus injection of cisplatin in humans
  Cancer Chemotherapy and Pharmacology, 1988
• Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical data
  International Journal of Radiation Oncology*Biology*Physics, 1987
• Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck
  British Journal of Cancer, 1986
• Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin
  Cancer, 1985